Active ingredient of Ozempic® and Wegovy®

Semaglutide: the brands, the price of every route, and how it fared against tirzepatide

AM Rx providers can prescribe either semaglutide brand, or compounded semaglutide where appropriate, after reading your health history online. Prices checked November 2026.

  • STEP 1 trial (brand-name semaglutide, 2.4 mg): 14.9% average weight loss by week 68, against 2.4% on placebo1
  • Wegovy or Ozempic for as little as $25/mo with insurance that covers the drug*
  • Compounded semaglutide at $199/mo, or from $106/mo for a 3-month supply†
  • Available in every state and Washington, DC, for adults who qualify
Five Wegovy pens, one of each dose strength
Wegovy · $25/mo at best, with coverage*
Two Ozempic pens
Ozempic · the type 2 diabetes brand
Illustration of a medication vial standing in front of a cardboard shipping box
Compounded semaglutide · from $106/mo†
Phone screen asking “What is your desired weight?” beside a medication card
A licensed provider reads every intake
$25/moLowest brand-name copay, for plans that cover the drug*
$106/moCompounded semaglutide, 3-month supply†
$39First month of AM Rx membership
What kind of medicine is semaglutide?

A prescription GLP-1 drug from Novo Nordisk, injected weekly or swallowed daily. It copies a gut hormone released after eating, which leaves you full sooner and steadies blood sugar.2

Semaglutide or tirzepatide: which did better?

For weight, tirzepatide (Zepbound®, Mounjaro®). The single trial comparing them ended at 20.2% average loss for tirzepatide and 13.7% for semaglutide after 72 weeks.3 Semaglutide is cheaper through AM Rx, and only it has a tablet. Go to the comparison.

*Needs commercial insurance that pays for the prescribed brand, plus Novo Nordisk’s savings offer, which deducts at most $100 per one-month fill.4,5 Public coverage such as Medicare or Medicaid does not qualify. †$199 month to month. No compounded drug is FDA-approved. Membership is billed apart: $39 the first month, $135 each month after.

Safety summary: Semaglutide has a boxed warning concerning thyroid C-cell tumors. Do not use it after a diagnosis of medullary thyroid carcinoma in you or a family member, or if you have MEN 2. See all safety information.

Semaglutide 2.4 mg took off 14.9% of body weight, on average, over 68 weeks

The number is from STEP 1, which followed 1,961 adults without diabetes whose BMI was in the obesity range, or in the overweight range alongside a weight-related illness. Those given placebo lost 2.4%. One in two people on semaglutide (50.5%) shed 15% or more; 4.9% of the placebo group managed that.1

Weight lost at STEP 1’s
14.9% average
37lbs

Tablet (25 mg) to highest injection (7.2 mg): 34 to 47 lbs

Simple multiplication of a trial average, not a prediction; individual results differ. The range runs from 13.6% (25 mg tablet, week 64) to 18.7% (7.2 mg injection, week 72).6,7 These studies used Novo Nordisk’s product, not compounded semaglutide.

Weight change in each semaglutide trial

TrialLengthDoseSemaglutidePlacebo
STEP 1168 weeks2.4 mg weekly14.9%2.4%
STEP 2, adults with type 2 diabetes868 weeks2.4 mg weekly9.6%3.4%
STEP 59104 weeks2.4 mg weekly15.2%2.6%
STEP UP772 weeks7.2 mg weekly18.7%3.9%
OASIS 4664 weeks25 mg tablet each day13.6%2.2%

Mean loss of starting weight in adults with obesity or overweight. These were separate studies, so compare rows with care.

What is semaglutide, and which brands is it sold under?

A single molecule with several labels. Which label is on the box settles the approved use, the maximum dose and what an insurer will pay.

Point of comparisonWegovyWeight and heart riskOzempicType 2 diabetesCompounded semaglutidePrescribed through AM Rx
FDA statusApprovedApprovedNot FDA-approved. No FDA review of its safety, effectiveness or quality10
Approved usesWeight loss and maintenance; fewer heart attacks and strokes in adults with heart disease plus obesity or overweight; MASH liver disease (injection only)2Blood sugar control in type 2 diabetes, plus heart and kidney protection for some adults who have it. Not weight loss11None. Results from brand trials cannot be assumed for it
FormsWeekly pen, 0.25 to 7.2 mg; daily tablet, 1.5 to 25 mgWeekly pen, 0.25 to 2 mg; daily tablet, 1.5 to 9 mg12A vial; each dose is drawn into a syringe
Lowest price, November 2026$25/mo at best with coverage; $149/mo self-pay$199/mo; from $106/mo for a 3-month supply

How does semaglutide work?

Semaglutide shares 94% of its structure with GLP-1, a gut hormone, and it binds to albumin in the blood, so half of a dose is still present about a week later. It signals for more insulin when blood sugar runs high, keeps food in the stomach longer and cuts calorie intake, probably through appetite centers in the brain.2

The Wegovy label says fat makes up more of the lost weight than lean tissue does.2

Brand by brand, in order of approval13

  • Ozempic (2017). Pen or tablet for type 2 diabetes; weight loss use is off-label. Read more.
  • Rybelsus® (2019). A type 2 diabetes tablet, still an FDA-listed prescription product.
  • Wegovy (2021). The weight brand: a pen and, since December 2025, a tablet. Read more.
  • Generic. None holds final FDA approval.

Getting semaglutide through AM Rx, step by step

No clinic visit is needed. Membership ($39 the first month, $135 each month after) covers provider review, insurance coordination, unlimited secure messages, monthly video or phone visits on request, a weight loss coach and the AM Rx app.

From intake to first dose in five steps
1. Fill in the online intake

Tell us your medical history, the medicines you take, your weight and what you hope to achieve.

Phone screen asking “What is your desired weight?” beside a medication card
2. A provider reviews it

A U.S.-licensed provider reviews it in 1 to 2 business days and replies by secure message. No live appointment is required.

Hands holding a phone that shows a message thread with a provider
3. For Wegovy or Ozempic, we contact your insurer

Our insurance coordinators file the prior authorization. Insurers mostly answer in 2 to 14 business days. If the first request is denied we can file again, up to three in all. Approved prescriptions go to the pharmacy you pick.

A woman laughing while looking at her phone
4. For compounded semaglutide, a pharmacy ships it

The partner pharmacy needs 2 to 7 business days, as a rule, to prepare the order, then sends it by 2-day delivery, supplies included. The usual wait after prescribing is 2 to 9 business days.

Illustration of a medication vial standing in front of a cardboard shipping box
5. Move up in dose with your provider

The dose rises roughly every four weeks. Mention side effects first; your provider can hold the current dose longer.

A man in a knit hat holding a phone and a mug

Semaglutide side effects: what to expect and how common each is

Digestive complaints top the list. Across Wegovy’s weight trials, 73% of adults taking 2.4 mg reported one or more, compared with 47% of the placebo group.2

EffectWegovy 2.4 mgPlaceboOzempic 0.5 mgOzempic 1 mgPlacebo
Nausea44%16%15.8%20.3%6.1%
Diarrhea30%16%8.5%8.8%1.9%
Vomiting24%6%5%9.2%2.3%
Constipation24%11%5%3.1%1.5%
Stomach pain20%10%7.3%5.7%4.6%

Percentage of adults who reported the effect: Wegovy in weight trials, Ozempic in diabetes trials, as printed in each label.2,11 Compounded semaglutide was not studied.

Nausea, vomiting and diarrhea mostly came while doses were going up. With Wegovy 2.4 mg, side effects led 6.8% of adults to quit treatment (3.2% with placebo), and 3% noticed hair loss (1% with placebo).2

On November 9, 2026 the FDA told makers of all GLP-1 drugs to add label language on a potential rise in the risk of NAION, an uncommon optic nerve condition that can abruptly take the sight of one eye: 6.4 cases per 100,000 person-years in pooled trials, against 3.8 with comparators.14 For the whole drug class, read GLP-1 side effects.

Easing an upset stomach

  • Eat smaller meals more often.
  • While you feel sick in the first days, skip fatty and high-fiber foods.
  • Keep up your fluids. If you are constipated, bring fiber back in slowly.15
  • Ask whether the next dose increase can wait four weeks.2

Call for medical help at once if you have

  • Intense abdominal pain that persists, whether or not you vomit
  • Pain high in the abdomen along with fever, yellowing eyes or skin, or pale clay-colored stools
  • Swelling around the face, mouth or throat, labored breathing, or a severe rash
  • Vision that suddenly fails in one eye
  • A neck lump, hoarseness that lingers, or difficulty swallowing

Semaglutide dosing schedule for each brand and form

All forms begin with a small dose that is raised roughly every four weeks, which keeps stomach side effects in check.

StageWegovy pen, once a weekOzempic pen, once a weekWegovy tablet, once a day
First month0.25 mg0.25 mg1.5 mg
Second month0.5 mg0.5 mg4 mg
Third month1 mgStay at 0.5 mg or move to 1 mg9 mg
Fourth month1.7 mg1 mg; 2 mg only if required25 mg
From month five2.4 mg, or remain at 1.7 mg. Adults needing more weight loss can later move to 7.2 mgKept at 0.5 mg, 1 mg or, at most, 2 mg25 mg, continued
  1. 0.25 mgMonth 1
  2. 0.5 mgMonth 2
  3. 1 mgMonth 3
  4. 1.7 mgMonth 4
  5. 2.4 mgMonth 5 on
  6. 7.2 mgOptional

From the Wegovy and Ozempic labels.2,11 Injection months are four weeks and tablet months 30 days. Ozempic goes up only when blood sugar needs more control.

Taking it, and handling a missed dose

Inject on the same weekday every week, at any hour, with food or without, into the abdomen, thigh or upper arm; change the exact spot every time. Wegovy tablets are swallowed first thing in the morning, stomach empty, with no more than 4 ounces of water, and nothing else for 30 minutes.2

A missed Wegovy injection can still be taken provided more than 2 days remain before the next one is due; if not, leave it out. Ozempic allows 5 days to catch up.2,11

Measuring compounded semaglutide

Each dose is pulled from the vial into a syringe in the amount your prescription states. This page prints no units chart: the FDA has reports of patients giving themselves doses 5 to 20 times larger than intended because milligrams, milliliters and syringe units were confused.16 Unsure about any step? Message your care team first. Brand pen doses are covered in Ozempic dosage.

Semaglutide vs tirzepatide: results when the two were tested together

Both direct trials ended with more weight lost on tirzepatide. Semaglutide answers with a wider set of approved uses, a tablet and a smaller price.

Which one takes off more weight?

On average, tirzepatide. SURMOUNT-5 enrolled 751 adults who had obesity but not type 2 diabetes, each on the top dose they could tolerate: 10 or 15 mg of tirzepatide, or 1.7 or 2.4 mg of semaglutide. At week 72 the tirzepatide group had lost 20.2% of body weight on average and the semaglutide group 13.7%. Participants knew which drug they took, and Eli Lilly, tirzepatide’s maker, paid for the trial.3

What about type 2 diabetes?

SURPASS-2 ran for 40 weeks in 1,879 adults already taking metformin. Tirzepatide at 5, 10 and 15 mg lowered A1C by 2.01, 2.24 and 2.30 points; semaglutide 1 mg lowered it by 1.86. Weight came down 16.8, 20.5 and 24.7 lb with tirzepatide and 12.6 lb with semaglutide.17,18

Other differences

Nausea was about as common on both in SURPASS-2: 17% to 22% with tirzepatide, 18% with semaglutide.17 Semaglutide 2.4 mg reduced heart attacks, strokes and cardiovascular deaths by 20% in SELECT, a placebo-controlled trial in adults with heart disease; Zepbound has no heart indication.19,20 Tirzepatide’s label warns that it can weaken birth control pills, and Ozempic’s does not.11,18

Point of comparisonSemaglutidein Wegovy and OzempicTirzepatidein Zepbound and Mounjaro
ReceptorsGLP-1GIP and GLP-1
First US approval2017 (Ozempic); Wegovy 20212022 (Mounjaro); Zepbound 2023
SURMOUNT-5 weight loss, 72 weeks13.7% on 1.7 or 2.4 mg20.2% on 10 or 15 mg
SURPASS-2 weight loss, 40 weeks12.6 lb on 1 mg16.8 to 24.7 lb on 5 to 15 mg
Approved uses beyond weightHeart risk reduction, MASH (Wegovy); type 2 diabetes (Ozempic)Obstructive sleep apnea (Zepbound); type 2 diabetes (Mounjaro)
FormsInjection or tabletInjection only
Manufacturer self-pay, starting dose$199/mo for two fills, then $349 (pen)$299/mo (Zepbound 2.5 mg)
Manufacturer self-pay, later doses$349/mo (Wegovy up to 2.4 mg)$399/mo (Zepbound 5 mg); $449/mo (7.5 mg and up, refilled within 45 days)
Compounded through AM Rx$199/mo; from $106/mo for a 3-month supply$329/mo; from $216/mo for a 3-month supply
AM Rx bundle with membership$217 the first month, $297/mo after$349 the first month, $449/mo after

Approvals belong to the brand-name products; years, receptors and uses come from labels and FDA records.13,14,18,20 Zepbound prices are Eli Lilly’s self-pay prices in November 2026.21 Compounded drugs were not part of these trials.

Prices checked November 19, 2026

Semaglutide cost: all the routes and what each one charges

Depending on the route, a month of the same molecule runs from $25 to over $1,000.

RouteMonthly priceTerms
Wegovy or Ozempic, commercial plan covers it$25 at the lowestThrough Novo Nordisk’s savings offer, which removes up to $100 from a one-month fill. Closed to people with government insurance.4,5
Wegovy pen, paying yourself$349 at any dose from 0.25 to 2.4 mg; $399 at 7.2 mgNew patients pay $199 a fill for their first two fills at 0.25 mg or 0.5 mg. Ends December 31, 2026.4
Wegovy or Ozempic tablets, paying yourself$149 (1.5 mg), $199 (4 mg), $299 (9 mg, and Wegovy 25 mg)A bottle of 30 tablets per month.4,12
Ozempic pen, paying yourself$349 for the 0.25/0.5 mg pen or the 1 mg pen; $499 for the 2 mg penThe $199 new-patient price applies here too, until December 31, 2026. Ozempic’s approval is for type 2 diabetes.12
Compounded semaglutide from AM Rx$199; from $106 for a 3-month supplyShipping is in the price. Membership is extra. Not FDA-approved.
AM Rx bundle$217 the first month, $297 afterCovers membership and compounded semaglutide together.
Medicare GLP-1 Bridge (Wegovy)$50 copayFor Part D enrollees who qualify, from July 1, 2026 to December 31, 2027. A prior authorization is required.22
Ozempic at list price$1,027.51 a packageWhat the manufacturer charges before insurance or offers.23

Novo Nordisk sets the brand prices and can revise them.

Semaglutide cost with insurance

If a commercial plan covers the brand you are prescribed, Novo Nordisk’s savings offer can take a fill down to $25. The offer absorbs up to $100 of your copay on a one-month fill, $200 on two months and $300 on three. A $95 copay therefore drops to $25, while a $210 copay drops to $110.4,5

Insurers have generally paid for GLP-1 drugs prescribed for diabetes. For weight loss, KFF’s 2026 employer survey found that 18% of firms with at least 200 workers cover them.24 Where a prior authorization is needed, AM Rx files it and the insurer makes the call. Our GLP-1 insurance checker goes further.

Semaglutide cost without insurance

If no plan covers it, the self-pay prices above are honored in three places: NovoCare, Novo Nordisk’s home-delivery pharmacy; retail pharmacies that take part in the savings offer; and GoodRx, whose Wegovy coupon is Novo Nordisk’s own offer run by GoodRx.25 The GoodRx Wegovy guide has the details. Every fill requires a prescription. Because self-pay sits outside insurance, the cost cannot be reimbursed or applied to a deductible.12

Which semaglutide offers end on December 31, 2026?

Two. One is the $199 starter price on Wegovy and Ozempic pens, and its deadline depends on where you fill.

  • Retail pharmacy: filled by December 31, 2026, with no savings offer used in the past 365 days.4
  • NovoCare home delivery: written and received by December 31, 2026 and shipped by January 31, 2027, with no earlier fill of that injection through NovoCare.26

From the third fill the price is $349. The other is the $25 savings offer for Rybelsus; that expiry does not apply to Ozempic.5

Not ending then: the $25 Wegovy offer has no stated end, though Novo Nordisk can withdraw it without notice, and the Ozempic offer runs up to 48 months once activated.4,5 Eli Lilly’s Zepbound savings card also stops on December 31, 2026.21

Manufacturer savings and government insurance

Novo Nordisk’s savings offers are closed to people covered by Medicare, Medicaid, the VA, TRICARE or another public program.4 Ozempic is on most Medicare Part D plans for people with type 2 diabetes.12 For weight, the Medicare GLP-1 Bridge prices Wegovy at a $50 copay per month.22

What you pay through AM Rx

AM Rx bills for membership ($39 the first month, $135 each month after) and, where a provider prescribes it, compounded medication. The table adds the two together.

How you payFirst monthLater months
Membership plus compounded, month to month$238 ($39 + $199)$334 ($135 + $199)
Membership plus compounded, 3-month supply$39, plus the supplyFrom $241 ($135 + $106)
Bundle$217$297

The 3-month figure is an average per month. The supply is sent in one shipment.

Against month-to-month billing, the bundle works out $21 cheaper in the first month and $37 cheaper in each later one. With the bundle, a dose above the standard schedule can add fees, and a refund is issued when the provider’s review finds you clinically ineligible. Brand-name medication is paid for at your pharmacy. We take HSA and FSA cards, and you can cancel in the portal at any time.

Cheaper is not the same as equivalent. Compounded semaglutide has no FDA approval. Before you decide on price, read where the FDA stands.

Compounded semaglutide: where the FDA stands and what AM Rx offers

It is not Ozempic, not Wegovy, not a generic and not FDA-approved.

What compounding is

Compounding means a licensed pharmacy prepares a drug to fill one patient’s prescription. The FDA does not approve compounded drugs, and nobody at the agency reviews their safety, effectiveness or quality ahead of sale. It advises using one only if no approved drug can meet the patient’s medical need.10 A compounded drug is not a generic either. Generics are FDA-approved; compounded drugs are not.27

The FDA’s position today

The FDA declared the shortage of semaglutide injection over on February 21, 2025. The extra room pharmacies had been given to copy it during the shortage ended in April 2025, after a court ruling on April 24, 2025. For outsourcing facilities it ended on May 22, 2025.28

An FDA update dated April 1, 2026 says pharmacy compounding has to be for one named patient holding a prescription. A pharmacy is barred from producing, “regularly or in inordinate amounts”, drugs that are essentially copies of a product already on the market. The exception is a change, documented by the prescriber, that makes a significant difference for the patient in question.28

Semaglutide with something added, vitamin B12 for instance, may still be treated as a copy if it is injected the same way and its strength falls within 10% of the commercial drug.28

What the FDA has reported, and what it advises

  • Overdoses. People drawing doses from vials have injected five to twenty times the prescribed amount, and some went to hospital.16
  • Salt forms. The sodium and acetate salts of semaglutide are not the active ingredient in the approved drugs, and the FDA knows of no lawful basis for compounding with them.10
  • Reports. By May 31, 2026 the FDA had logged 990 adverse event reports involving compounded semaglutide, a figure it considers an undercount.10
  • Advice. Fill the prescription at a state-licensed pharmacy, refuse an injectable that turns up warm, throw out a multi-dose vial once 28 days have passed since first use, and distrust sellers who claim their compounded product equals an FDA-approved one.10

What AM Rx offers

Compounded semaglutide is prescribed through AM Rx solely where a licensed provider judges it appropriate for the individual patient, and a partner pharmacy ships it to your home. AM Rx makes no claim that it matches Wegovy or Ozempic or performs as well. The trial figures quoted here were measured with those two brands.

Get Started

AM Rx members

What members say about the AM Rx weight loss program

One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
Michelle, 33 | Lost 48 pounds
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Michael, 37 | Lost 29 pounds
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Susanne, 60 | Lost 33 pounds
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
Rachel | AM Rx Member
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
John | AM Rx Member
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Sara | AM Rx Member

Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.

A man at home smiling at his laptop
Your care team

A licensed provider decides whether semaglutide, and which form of it, suits you

A U.S.-licensed, board-certified physician or nurse practitioner reads your intake before anything is prescribed. If semaglutide is not a safe choice for you, they will tell you so.

50 states and DCU.S.-licensed physicians and nurse practitioners, wherever you live
No appointment to bookA provider reads your intake online and replies by secure message
Open every dayPhone support Monday to Friday 9am to 8pm ET, weekends 12pm to 8pm ET

The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.

Semaglutide FAQs

What is the cheapest way to get semaglutide right now?

With a commercial plan that pays for Wegovy or Ozempic, Novo Nordisk’s savings offer can take a fill down to $25. Paying cash, the lowest brand price is $149 a month for 1.5 mg tablets.4 Compounded semaglutide from AM Rx starts at $106 a month plus membership, and has no FDA approval.

Is tirzepatide stronger than semaglutide for weight loss?

On average it is. SURMOUNT-5 ran for 72 weeks in adults with obesity and ended with a 20.2% mean weight loss on tirzepatide and 13.7% on semaglutide.3 The sponsor was Eli Lilly, tirzepatide’s maker. A group average cannot tell you how you will respond.

Is compounded semaglutide approved by the FDA?

No. Compounded semaglutide lacks FDA approval, and compounded drugs are sold without FDA review of their safety, effectiveness or quality.10 The trial figures on this page were measured with Wegovy and Ozempic. No compounded product was part of those studies.

Is compounded semaglutide the same as generic Ozempic?

No. Generic drugs are copies that the FDA has approved; compounded drugs have no approval, and the FDA treats them as different things.27 As of November 2026 no generic semaglutide holds final approval. FDA records show a single generic application, and its approval is only tentative.13

When does the $199 semaglutide offer end?

On December 31, 2026. It gives new patients a $199 price on each of their first two fills of a Wegovy or Ozempic pen at 0.25 mg or 0.5 mg. Retail pharmacies must fill the prescription by that day; NovoCare home delivery must receive it by then and ship by January 31, 2027.4,26

What is the monthly price of semaglutide without insurance?

From $149 to $499 for the brands, at Novo Nordisk’s November 2026 self-pay prices: Wegovy pens $349 ($399 at 7.2 mg), Ozempic pens $349 ($499 for 2 mg), tablets $149 to $299.4,12 Compounded semaglutide from AM Rx is $199, with membership on top.

Does insurance cover semaglutide for weight loss?

Some plans do. Insurers have generally paid for GLP-1 drugs prescribed for diabetes, yet fewer than one in five large employers (18% in KFF’s 2026 survey) cover them for weight loss.24 AM Rx’s insurance coordinators file any prior authorization a brand-name prescription requires. The insurer decides.

How soon does semaglutide start working?

Within days, though weight takes longer. Its blood level peaks 1 to 3 days after a dose and levels off after 4 to 5 weeks.2 The first month’s 0.25 mg is only a starting step. In STEP 4, adults were down 10.6% on average at week 20.29

Important safety information

This summary follows the Wegovy and Ozempic prescribing information.2,11 The FDA has not evaluated compounded semaglutide, so treat each warning as applying to it as well.

Boxed warning: tumors of the thyroid C cells

Rodents given semaglutide developed thyroid C-cell tumors. Whether it does the same in humans, including a cancer named medullary thyroid carcinoma (MTC), has not been established. Nobody who has had MTC, or who has a family member who had it, should take semaglutide, and nor should anyone with MEN 2 (Multiple Endocrine Neoplasia syndrome type 2). Report a lump in the neck, difficulty swallowing, breathlessness or a hoarse voice that persists.

Semaglutide is not for you if

  • MTC has ever been diagnosed in you or a family member, or you have MEN 2.
  • A past dose of semaglutide, or any ingredient in the product, gave you a serious allergic reaction.

What your provider needs to know first

  • Any history of pancreatitis, gallbladder disease or kidney disease, and any severe stomach condition such as gastroparesis.
  • Type 2 diabetes, diabetic eye disease, and use of insulin or a sulfonylurea.
  • An operation or procedure coming up that involves anesthesia or deep sedation.
  • Pregnancy, plans for pregnancy (semaglutide is stopped at least 2 months ahead) or breastfeeding.
  • Any other GLP-1 drug you take, and any medicine taken by mouth.

Sources

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Wegovy (semaglutide) injection and tablets prescribing information. Novo Nordisk. Revised June 2026. https://www.novo-pi.com/wegovy.pdf
  3. Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
  4. Novo Nordisk. Wegovy Savings Offer terms and conditions. https://www.wegovyterms.com
  5. Novo Nordisk. Ozempic and Rybelsus Savings Offer terms and conditions. https://www.savingscardeligibility.com
  6. Wharton S, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). N Engl J Med. 2025;393(11):1077-1087. https://pubmed.ncbi.nlm.nih.gov/40934115/
  7. Wharton S, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). Lancet Diabetes Endocrinol. 2025;13(11):949-963. https://pubmed.ncbi.nlm.nih.gov/40961952/
  8. Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. https://pubmed.ncbi.nlm.nih.gov/33667417/
  9. Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091. https://pubmed.ncbi.nlm.nih.gov/36216945/
  10. FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Current as of October 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  11. Ozempic (semaglutide) injection prescribing information. Novo Nordisk. Revised May 2026. https://www.novo-pi.com/ozempic.pdf
  12. Novo Nordisk. Ozempic cost and insurance coverage. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
  13. FDA. Drugs@FDA data for semaglutide products (openFDA). Updated November 18, 2026. https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22SEMAGLUTIDE%22&limit=100
  14. FDA. FDA requires safety labeling changes for GLP-1 receptor agonists due to potential increased risk of rare but serious eye condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
  15. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity (Silver Spring). 2025;33(8):1475-1503. https://pubmed.ncbi.nlm.nih.gov/40445127/
  16. FDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
  17. Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
  18. Mounjaro (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  19. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/
  20. Zepbound (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  21. Eli Lilly and Company. Zepbound savings page, terms and conditions. https://zepbound.lilly.com/savings
  22. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
  23. Novo Nordisk. Ozempic list price (NovoPricing). https://www.novopricing.com/ozempic.html
  24. KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
  25. GoodRx. Wegovy offer terms and conditions, administered on behalf of Novo Nordisk. September 2026. https://www.grxstatic.com/bds/wegovy-offer-terms-and-conditions.pdf
  26. Novo Nordisk. NovoCare home delivery terms. https://www.novocaredeliveryterms.com
  27. FDA. Compounding and the FDA: questions and answers. Current as of September 16, 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  28. FDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Updated April 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  29. Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4). JAMA. 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/

Reviewed by the AM Rx care team. Web pages, prices and program terms were last checked on November 19, 2026.

Ready to ask a provider about semaglutide?

A licensed provider reads your intake and tells you which form, brand-name or compounded, fits your health history. Your first month of membership costs $39.

Get Started